CA Patent

CA2584338A1 — Gabapentin prodrug sustained release oral dosage forms

Assigned to Arbor Pharmaceuticals LLC · Expires 2006-05-11 · 20y expired

What this patent protects

Sustained release oral dosage forms of a gabapentin prodrug, 1 {[(a-isobutanoyloxyethoxy)carbonyl]aminomethyl} 1 cyclohexane acetic acid, are disclosed. The dosage forms are useful for treating or preventing diseases and disorders for which gabapentin is therapeutically effective…

USPTO Abstract

Sustained release oral dosage forms of a gabapentin prodrug, 1 {[(a-isobutanoyloxyethoxy)carbonyl]aminomethyl} 1 cyclohexane acetic acid, are disclosed. The dosage forms are useful for treating or preventing diseases and disorders for which gabapentin is therapeutically effective.

Drugs covered by this patent

Patent Metadata

Patent number
CA2584338A1
Jurisdiction
CA
Classification
—
Expires
2006-05-11
Drug substance claim
No
Drug product claim
No
Assignee
Arbor Pharmaceuticals LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.